Objective To explore the clinical efficacy of self-defined Calming wind and resolving phlegm decoction on the wind-phlegm syndrome and stasis in the recovery stage of ischemia stroke. Methods 69 cases with ischemic stroke collected in our hospital from January 2010 to March 2013 were randomly divided into experimental group (35 cases) and control group (34 cases). The experimental group was treated with self-defined calming wind and resolving phlegm decoction, while control group was treated with ginaton capsule. The clinical efficacy and neurological symptom score of the two groups were compared. Results The total effective rate in the experimental group was 91.43%, while the control group was 79.41%, the difference of the total effective rate between two groups was statistically significant (P<0.05). There was significant difference in neurological symptom score of the two groups between before and after treatment (P < 0.05). There was significant difference in neurological symptom score after treatment between two groups (P<0.05). Conclusion The clinical efficacy of self-defined calming wind and resolving phlegm decoction on the wind-phlegm syndrome and stasis in the recovery stage of ischemia stroke is better than that of western medicine treatment group, which is worthy of clinical application.%目的探讨自拟熄风化痰汤治疗缺血性中风恢复期（风痰瘀阻型）的临床疗效。方法选取2010年1月～2013年3月在本院治疗的缺血性中风患者69例，按照随机数字表法分为实验组35例及对照组34例，实验组以自拟熄风化痰汤治疗，对照组以银杏叶胶囊治疗。比较两组患者的临床疗效和神经功能症状评分情况。结果实验组患者的总有效率为91.43%，对照组为79.41%，两组总有效率比较，差异有统计学意义（P＜0.05）。两组患者神经症状评分治疗后与治疗前比较，差异有统计学意义（P＜0.05）；治疗后实验组与对照组比较，差异有统计学意义（P＜0.05）。结论自拟熄风化痰汤治疗缺血性中风恢复期（风痰瘀阻型）疗效优于西药治疗组，值得临床推广应用。
展开▼
